BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25265904)

  • 1. Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients.
    Srivastava G; Assi J; Kashat L; Matta A; Chang M; Walfish PG; Ralhan R
    BMC Cancer; 2014 Sep; 14():726. PubMed ID: 25265904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers.
    Ralhan R; He HC; So AK; Tripathi SC; Kumar M; Hasan MR; Kaur J; Kashat L; MacMillan C; Chauhan SS; Freeman JL; Walfish PG
    PLoS One; 2010 Nov; 5(11):e14130. PubMed ID: 21152431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis.
    Ralhan R; Cao J; Lim T; Macmillan C; Freeman JL; Walfish PG
    BMC Cancer; 2010 Jun; 10():331. PubMed ID: 20579375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
    Kunavisarut T; Kak I; Macmillan C; Ralhan R; Walfish PG
    BMC Cancer; 2012 Nov; 12():523. PubMed ID: 23153310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear Ep-ICD expression is a predictor of poor prognosis in "low risk" prostate adenocarcinomas.
    Assi J; Srivastava G; Matta A; MacMillan C; Ralhan R; Walfish PG
    PLoS One; 2015; 10(2):e0107586. PubMed ID: 25695234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma.
    He HC; Kashat L; Kak I; Kunavisarut T; Gundelach R; Kim D; So AK; MacMillan C; Freeman JL; Ralhan R; Walfish PG
    PLoS One; 2012; 7(9):e42893. PubMed ID: 23049733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
    Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
    BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
    Zhang B; Liu FF; Ma YJ; Gu F
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
    Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.
    Alberti S; Ambrogi F; Boracchi P; Fornili M; Querzoli P; Pedriali M; La Sorda R; Lattanzio R; Tripaldi R; Piantelli M; Biganzoli E; Coradini D
    Jpn J Clin Oncol; 2012 Dec; 42(12):1128-37. PubMed ID: 23072840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
    Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
    Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
    Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.
    Spizzo G; Obrist P; Ensinger C; Theurl I; Dünser M; Ramoni A; Gunsilius E; Eibl G; Mikuz G; Gastl G
    Int J Cancer; 2002 Apr; 98(6):883-8. PubMed ID: 11948467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of CADM4 expression in invasive ductal carcinoma of the breast.
    Jang SM; Sim J; Han H; Ahn HI; Kim H; Yi K; Jun YJ; Rehman A; Chung MS; Jang K; Paik SS
    J Clin Pathol; 2013 Aug; 66(8):681-6. PubMed ID: 23559354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal expression of Nek2 and β-catenin in breast carcinoma: clinicopathological correlations.
    Wang S; Li W; Lv S; Wang Y; Liu Z; Zhang J; Liu T; Niu Y
    Histopathology; 2011 Oct; 59(4):631-42. PubMed ID: 22014044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of periostin in breast cancer cells.
    Ratajczak-Wielgomas K; Grzegrzolka J; Piotrowska A; Matkowski R; Wojnar A; Rys J; Ugorski M; Dziegiel P
    Int J Oncol; 2017 Oct; 51(4):1300-1310. PubMed ID: 28902360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma.
    Logullo AF; Stiepcich MM; Osório CA; Nonogaki S; Pasini FS; Rocha RM; Soares FA; Brentani MM
    Histopathology; 2011 Mar; 58(4):617-25. PubMed ID: 21371080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of vacuole membrane protein 1 and its prognostic value in invasive ductal carcinoma of the breast].
    Liu F; Niu Y; Liu N; Zhang W; Wang SL; Liu H; Zhang TX
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):86-9. PubMed ID: 23710913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.